Filing Details
- Accession Number:
- 0001415889-24-019269
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-03 17:58:57
- Reporting Period:
- 2024-07-01
- Accepted Time:
- 2024-07-03 17:58:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1484565 | Soleno Therapeutics Inc | SLNO | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1422484 | H James Mackaness | 203 Redwood Shores Pkwy, Ste 500 Redwood City CA 94065 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-07-01 | 1,568 | $41.22 | 61,385 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-07-01 | 5,622 | $41.63 | 55,763 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").
- This transaction was executed in multiple trades at prices ranging from $40.39 to $41.38. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
- This transaction was executed in multiple trades at prices ranging from $41.39 to $42.08. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.